20.07.2023 13:31:09
|
EQS-PVR: PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: PharmaSGP Holding SE
Notification of Major Holdings
1. Details of issuer
2. Reason for notification
3. Details of person subject to the notification obligation
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:
6. Total positions
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
8. Information in relation to the person subject to the notification obligation
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
10. Other explanatory remarks: Date
20.07.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | PharmaSGP Holding SE |
Lochhamer Schlag 1 | |
82166 Gräfelfing | |
Germany | |
Internet: | https://pharmasgp.com |
End of News | EQS News Service |
|
1684809 20.07.2023 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PharmaSGPmehr Nachrichten
27.11.24 |
Ausblick: PharmaSGP legt Quartalsergebnis vor (finanzen.net) | |
25.11.24 |
EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, Kauf (EQS Group) | |
25.11.24 |
EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, buy (EQS Group) | |
14.11.24 |
EQS-News: PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised (EQS Group) | |
14.11.24 |
EQS-News: PharmaSGP mit kräftigem Umsatzwachstum in 9M 2024 – Erhöhung der Umsatzprognose für FY 2024 (EQS Group) | |
05.11.24 |
EQS-News: CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 (EQS Group) | |
05.11.24 |
EQS-News: CEO-Wechsel bei der PharmaSGP Holding SE: Peter Gerckens folgt zum 01. Januar 2025 auf Natalie Weigand (EQS Group) | |
05.11.24 |
EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer (EQS Group) |